Congress Materials

Medical Information
India
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for India Healthcare Professionals. Would you like to proceed?

I am a healthcare professional registered to practice in IndiaYes, I am a healthcare professional
SelectI am a healthcare professional registered to practice in IndiaYes, I am a healthcare professional
I am a patient/caregiver residing in IndiaNo, go back to the patient portal
SelectI am a patient/caregiver residing in IndiaNo, go back to the patient portal
Non-India residents click here.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.
Oral Presentation
Kavakli K, Fuiman J, McKay J, Sun P, Rupon J February 9, 2023 EAHAD 2023 Hemophilia

Efficacy and Safety of Fidanacogene Elaparvovec in Adults With Moderately Severe to Severe Hemophilia B: the Phase 3 BENEGENE-2 Gene Therapy Trial

View Presentation
Poster
Rasko J, Chhabra A, Ducore JM, George LA, Giermasz A, High KA, McGuinn CE, O’Brien A, Rupon J, Samelson-Jones BJ, Smith LM, Sullivan SK, Teitel JM, Winburn I February 9, 2023 EAHAD 2023 Hemophilia

Patterns of Joint Bleeds in Patients With Hemophilia B Following Fidanacogene Elaparvovec Adeno-Associated Virus Gene Therapy

View Presentation
Poster
Rasko J, Bashirians G, Petropoulos CJ, Wrin T, Somanathan S, Paliwal Y, Henstock PV, da Fonseca Pereira C, Winburn I, Chhabra A February 9, 2023 EAHAD 2023 Hemophilia

Seroprevalence of Neutralizing Antibodies Against Adeno-Associated Virus Serotypes of Relevance to Gene Therapy in Europeans

View Presentation